{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T19:49:51Z","timestamp":1762458591837},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2007,10,1]],"date-time":"2007-10-01T00:00:00Z","timestamp":1191196800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Rev Endocrinol"],"published-print":{"date-parts":[[2007,10]]},"DOI":"10.1038\/ncpendmet0639","type":"journal-article","created":{"date-parts":[[2007,9,24]],"date-time":"2007-09-24T16:57:43Z","timestamp":1190653063000},"page":"721-725","source":"Crossref","is-referenced-by-count":18,"title":["Tumor-induced osteomalacia: the importance of measuring serum phosphorus levels"],"prefix":"10.1038","volume":"3","author":[{"given":"Florencia","family":"Halperin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronald J","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean E","family":"Mulder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BFncpendmet0639_CR1","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/S8756-3282(00)00334-3","volume":"27","author":"R Kumar","year":"2000","unstructured":"Kumar R (2000) Tumor-induced osteomalacia and the regulation of phosphate homeostasis. Bone 27: 333\u2013338","journal-title":"Bone"},{"key":"BFncpendmet0639_CR2","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1001\/jama.294.10.1260","volume":"294","author":"SM Jan de Beur","year":"2005","unstructured":"Jan de Beur SM (2005) Tumor-induced osteomalacia. JAMA 294: 1260\u20131267","journal-title":"JAMA"},{"key":"BFncpendmet0639_CR3","doi-asserted-by":"publisher","first-page":"F1170","DOI":"10.1152\/ajprenal.00072.2005","volume":"289","author":"TJ Berndt","year":"2005","unstructured":"Berndt TJ  et al. (2005) \u201cPhosphatonins\u201d and the regulation of phosphorus homeostasis. Am J Physiol Renal Physiol 289: F1170\u2013F1182","journal-title":"Am J Physiol Renal Physiol"},{"key":"BFncpendmet0639_CR4","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1359\/JBMR.0301264","volume":"19","author":"T Shimada","year":"2004","unstructured":"Shimada T  et al. (2004) FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis. J Bone Miner Res 19: 429\u2013435","journal-title":"J Bone Miner Res"},{"key":"BFncpendmet0639_CR5","doi-asserted-by":"publisher","first-page":"6500","DOI":"10.1073\/pnas.101545198","volume":"98","author":"T Shimada","year":"2001","unstructured":"Shimada T  et al. (2001) Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia. Proc Natl Acad Sci USA 98: 6500\u20136505","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFncpendmet0639_CR6","doi-asserted-by":"publisher","first-page":"1656","DOI":"10.1056\/NEJMoa020881","volume":"348","author":"KB Jonsson","year":"2003","unstructured":"Jonsson KB  et al. (2003) Fibroblast growth factor 23 in oncogenic osteomalacia and X-linked hypophosphatemia. N Engl J Med 348: 1656\u20131663","journal-title":"N Engl J Med"},{"key":"BFncpendmet0639_CR7","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1210\/jcem.86.2.7408","volume":"86","author":"KE White","year":"2001","unstructured":"White KE  et al. (2001) The autosomal dominant hypophosphatemic rickets (ADHR) gene is a secreted polypeptide overexpressed by tumors that cause phosphate wasting. J Clin Endocrinol Metab 86: 497\u2013500","journal-title":"J Clin Endocrinol Metab"},{"key":"BFncpendmet0639_CR8","doi-asserted-by":"publisher","first-page":"2055","DOI":"10.1210\/jc.2005-2105","volume":"91","author":"EA Imel","year":"2006","unstructured":"Imel EA  et al. (2006) Sensitivity of fibroblast growth factor 23 measurements in tumor-induced osteomalacia. J Clin Endocrinol Metab 91: 2055\u20132061","journal-title":"J Clin Endocrinol Metab"},{"key":"BFncpendmet0639_CR9","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/S0140-6736(75)92736-1","volume":"7929","author":"RJ Walton","year":"1975","unstructured":"Walton RJ  et al. (1975) Normogram for derivation of renal threshold phosphate concentration. Lancet 7929: 309\u2013310","journal-title":"Lancet"},{"key":"BFncpendmet0639_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/00000478-200401000-00001","volume":"28","author":"AL Folpe","year":"2004","unstructured":"Folpe AL  et al. (2004) Most osteomalacia-associated mesenchymal tumors are a single histopathologic entity: an analysis of 32 cases and a comprehensive review of the literature. Am J Surg Pathol 28: 1\u201330","journal-title":"Am J Surg Pathol"},{"key":"BFncpendmet0639_CR11","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1016\/S0140-6736(02)07846-7","volume":"359","author":"SM Jan de Beur","year":"2002","unstructured":"Jan de Beur SM  et al. (2002) Localisation of mesenchymal tumours by somatostatin receptor imaging. Lancet 359: 761\u2013763","journal-title":"Lancet"},{"key":"BFncpendmet0639_CR12","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.bone.2005.01.001","volume":"36","author":"JL Dupond","year":"2005","unstructured":"Dupond JL  et al. (2005) Oncogenic osteomalacia: diagnostic importance of fibroblast growth factor 23 and F-18 fluorodeoxyglucose PET\/CT scan for the diagnosis and follow-up in one case. Bone 36: 375\u2013378","journal-title":"Bone"},{"key":"BFncpendmet0639_CR13","doi-asserted-by":"publisher","first-page":"2467","DOI":"10.1210\/jcem.87.6.8688","volume":"87","author":"SM Jan de Beur","year":"2002","unstructured":"Jan de Beur SM  et al. (2002) Molecular pathogenesis of hypophosphatemic rickets. J Clin Endocrinol Metab 87: 2467\u20132473","journal-title":"J Clin Endocrinol Metab"},{"key":"BFncpendmet0639_CR14","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1210\/jcem.82.2.3765","volume":"82","author":"MJ Econs","year":"1997","unstructured":"Econs MJ  et al. (1997) Autosomal dominant hypophosphatemic rickets\/osteomalacia: clinical characterization of a novel renal phosphate-wasting disorder. J Clin Endocrinol Metab 82: 674\u2013681","journal-title":"J Clin Endocrinol Metab"},{"key":"BFncpendmet0639_CR15","doi-asserted-by":"publisher","first-page":"1748","DOI":"10.1056\/NEJM200205303462215","volume":"346","author":"F Paglia","year":"2002","unstructured":"Paglia F  et al. (2002) Octreotide for tumor-induced osteomalacia. N Engl J Med 346: 1748\u20131749","journal-title":"N Engl J Med"}],"container-title":["Nature Clinical Practice Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/ncpendmet0639.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ncpendmet0639","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ncpendmet0639.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T19:54:18Z","timestamp":1684439658000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/ncpendmet0639"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,10]]},"references-count":15,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2007,10]]}},"alternative-id":["BFncpendmet0639"],"URL":"https:\/\/doi.org\/10.1038\/ncpendmet0639","relation":{},"ISSN":["1745-8366","1745-8374"],"issn-type":[{"value":"1745-8366","type":"print"},{"value":"1745-8374","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,10]]}}}